{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:12:48Z","timestamp":1779307968472,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"APSS"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.cmi.2020.11.013","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T20:50:44Z","timestamp":1606510244000},"page":"633.e1-633.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study"],"prefix":"10.1016","volume":"27","author":[{"given":"Paola","family":"Stefanelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Bella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Pancheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasqualina","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Neri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Carannante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta","family":"Fabiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Simmaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iolanda","family":"Santino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Zuccali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Bizzarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Magnoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Paolo","family":"Benetollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Merler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Brusaferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Rezza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.11.013_bib1","article-title":"Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States","author":"Havers","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2020.11.013_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(20)31483-5","article-title":"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study","volume":"396","author":"Poll\u00e1n","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.11.013_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00941-20","article-title":"Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho","volume":"58","author":"Bryan","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2020.11.013_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237548","article-title":"Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data","author":"Naaber","year":"2020","journal-title":"Plos One"},{"key":"10.1016\/j.cmi.2020.11.013_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.4616","article-title":"Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2020.11.013_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104511","article-title":"Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)","author":"Nicol","year":"2020","journal-title":"J Clin Virology"},{"key":"10.1016\/j.cmi.2020.11.013_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.05.036","article-title":"Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection","author":"Chew","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2020.11.013_bib10","first-page":"965","article-title":"Estimated community seroprevalence of SARS-CoV-2 antibodies \u2014 two Georgia Counties","volume":"69","author":"Biggs","year":"2020","journal-title":"MMWR"},{"key":"10.1016\/j.cmi.2020.11.013_bib11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/s41591-020-0949-6","article-title":"Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China","volume":"26","author":"Xu","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2020.11.013_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study","volume":"396","author":"Stringhini","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.11.013_bib13","series-title":"Large-scale geographic seroprevalence surveys","year":"2020"},{"key":"10.1016\/j.cmi.2020.11.013_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25904","article-title":"Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China","author":"Wu","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cmi.2020.11.013_bib15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0140-6736(16)30164-7","article-title":"Use of serological surveys to generate key insights into the changing global landscape of infectious disease","volume":"88","author":"Metcalf","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.11.013_bib16","article-title":"Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults","author":"Ward","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.cmi.2020.11.013_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100466","article-title":"Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: results from an observational cohort study","volume":"25","author":"Martin","year":"2020","journal-title":"EClinicalMedicine"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20307096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20307096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:27:40Z","timestamp":1761118060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X20307096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1198743X20307096"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.11.013","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}